Literature DB >> 26400051

Serum and Aqueous Concentrations of Inflammatory Markers in Diabetic Macular Edema.

M Selim Kocabora1,2, Mehmet Erdem Telli2, Korhan Fazil2, Sevil Karaman Erdur1, Mustafa Ozsutcu1,2, Osman Cekic2,3, Kemal Turgay Ozbilen2.   

Abstract

PURPOSE: To investigate the relationship between the serum and aqueous levels of inflammatory markers and diabetic macular edema (DME).
METHODS: The study included four patient groups: the healthy control group (n = 23 eyes); the diabetic control group (n = 22 eyes); the groups with and without DME (n = 20 eyes and n = 22 eyes, respectively). The patients were evaluated based on their serum levels of HbA1c, C-reactive protein (CRP) and serum and aqueous levels of tumor necrosis factor-alpha (TNF-α).
RESULTS: Statistically significant differences were present for the serum CRP levels and for the aqueous TNF-α levels between the healthy control group and the group with DME (p = 0.004 and p = 0.03, respectively); for the serum TNF-α levels between the healthy control group and the groups without and with DME (p = 0.009 and p = 0.001, respectively).
CONCLUSIONS: Increased serum levels of CRP and serum and aqueous levels of TNF-α in DME suggest that inflammation is involved in the pathogenesis of DME.

Entities:  

Keywords:  C-reactive protein; diabetic retinopathy; inflammation; macular edema; tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2015        PMID: 26400051     DOI: 10.3109/09273948.2015.1034804

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  9 in total

1.  Concentration of acute phase factors in vitreous fluid in diabetic macular edema.

Authors:  Kazuhiro Kimura; Tomoko Orita; Yuka Kobayashi; Shigeo Matsuyama; Kazushi Fujimoto; Kazuhiko Yamauchi
Journal:  Jpn J Ophthalmol       Date:  2017-07-28       Impact factor: 2.447

2.  Clinical and experimental study on angiopoietin-like protein 8 associated with proliferative diabetic retinopathy.

Authors:  Chang-Xia Dong; Cai-Ping Song; Chun-Ping Zhang; Mei Dong; Xiu-Rong Gong; He-Ying Gao; Hong Wang
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

3.  Aqueous humor pentraxin-3 levels in patients with diabetes mellitus.

Authors:  M Mutlu; N Yuksel; T Takmaz; A S Dincel; A Bilgihan; H Altınkaynak
Journal:  Eye (Lond)       Date:  2017-06-02       Impact factor: 3.775

4.  The effect of systemic levels of TNF-alpha and complement pathway activity on outcomes of VEGF inhibition in neovascular AMD.

Authors:  Adnan H Khan; Charles O Pierce; Gabriella De Salvo; Helen Griffiths; Marie Nelson; Angela J Cree; Geeta Menon; Andrew J Lotery
Journal:  Eye (Lond)       Date:  2021-11-08       Impact factor: 4.456

5.  Peripheral blood metabolic and inflammatory factors as biomarkers to ocular findings in diabetic macular edema.

Authors:  Marc Figueras-Roca; Blanca Molins; Anna Sala-Puigdollers; Jessica Matas; Irene Vinagre; José Ríos; Alfredo Adán
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

6.  Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.

Authors:  Jian Guan; Na Cai; Li-Min Liu; Ning Zhao; Ning-Ning Liu
Journal:  Diabetes Ther       Date:  2020-04-30       Impact factor: 2.945

7.  Aqueous Humor Mediator and Cytokine Aberrations in Diabetic Retinopathy and Diabetic Macular Edema: A Systematic Review and Meta-Analysis.

Authors:  Jingyang Wu; Yifan Zhong; Song Yue; Kaibo Yang; Guisen Zhang; Lei Chen; Lei Liu
Journal:  Dis Markers       Date:  2019-11-23       Impact factor: 3.434

Review 8.  Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies.

Authors:  Lorena Olivares-González; Sheyla Velasco; Isabel Campillo; Regina Rodrigo
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

Review 9.  Inflammatory and angiogenic biomarkers in diabetic retinopathy.

Authors:  Snježana Kaštelan; Ivana Orešković; Filip Bišćan; Helena Kaštelan; Antonela Gverović Antunica
Journal:  Biochem Med (Zagreb)       Date:  2020-08-05       Impact factor: 2.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.